The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

NCT00002387 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Efavirenz

Sponsor

Merck Sharp & Dohme LLC